Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. (2023)

First Author: Liu X

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.04.012

PubMed Identifier: 37085049

Publication URI: http://europepmc.org/abstract/MED/37085049

Type: Journal Article/Review

Volume: 87

Parent Publication: The Journal of infection

Issue: 1

ISSN: 0163-4453